109153 ⎘
Structure or type of the nucleic acid; Type of nucleic acid acting by a non-sequence specific mechanism
HIGHLY KNOTTED MOLECULAR TOPOLOGIES FROM SINGLE-STRANDED NUCLEIC ACIDS
#2ENGINEERED MULTI-COMPONENT SYSTEM FOR IDENTIFICATION AND CHARACTERISATION OF T-CELL RECEPTORS AND T-CELL ANTIGENS
#3NEUROPROTECTIVE MOLECULES AND METHODS OF TREATING NEUROLOGICAL DISORDERS AND INDUCING STRESS GRANULES
#4COMPOSITIONS AND METHODS FOR GENOMIC EDITING BY INSERTION OF DONOR POLYNUCLEOTIDES
#5Heteromultivalent Nucleic Acid Scaffolds and Uses Thereof
#6ACTIVATORS OF TYPE III CAS PROTEINS
#7CELL PENETRATING PROTEIN-ANTIBODY CONJUGATES AND METHODS OF USE
#8NUCLEIC ACID-PEPTIDE-NUCLEIC ACID CONJUGATE MOLECULES AND METHODS OF MAKING THE SAME
#9VACCINIA VIRAL POLYMERASE-MEDIATED VIRAL REPLICATION
#10INHIBITOR OF NON-SPECIFIC BINDING OF NUCLEIC ACID, HYBRIDIZATION REAGENT AND NUCLEIC ACID HYBRIDIZATION METHOD
#11Protecting RNAs from degradation using engineered viral RNAs
#12HIGHLY KNOTTED MOLECULAR TOPOLOGIES FROM SINGLE-STRANDED NUCLEIC ACIDS
#13Methods for therapeutic use of exosomes and Y-RNAS
#14Compositions and methods for genomic editing by insertion of donor polynucleotides
#15Method of nonspecific target capture of nucleic acids
#16Method for inhibiting the expression of inflammation promoting factors
#17Engineered multi-component system for identification and characterisation of T-cell receptors and T-cell antigens
#18Compositions and methods for genomic editing by insertion of donor polynucleotides
#19NEUROPROTECTIVE MOLECULES AND METHODS OF TREATING NEUROLOGICAL DISORDERS AND INDUCING STRESS GRANULES
#20Protecting RNAs from degradation using engineered viral RNAs
#21Engineered multi-component system for identification and characterisation of T-cell receptors and T-cell antigens
#22Expression Inhibitor of Inflammation Promoting Factor, Screening Method for Active Ingredient Thereof, Expression Cassette Useful for Said Method, Diagnostic Agent and Diagnosis Method
#23Nucleic acid aptamer AS1411 modified DNA tetrahedron and preparation method thereof
#24Cell penetrating protein-antibody conjugates and methods of use
#25Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules
#26Compositions and methods for treating cancer, inhibiting cell proliferation, and inducing cell death
#27Double-stranded and single-stranded RNA molecules with 5′ triphosphates and their use for inducing interferon
#28Methods and compositions for interference with DNA polymerase and DNA synthesis
#29Therapeutic polynucleotides, compositions, and methods
#30Method of nonspecific target capture of nucleic acids
#31Piggy back delivery of nucleic acids into organisms
#32Methods and compositions involving immunostimulatory oligodeoxynucleotides
#33CONSTRUCTION OF CELL PENETRATING NUCLEIC ACIDS
#34Levels and/or Sustainability of DNA-based Gene Expression
#35Double-stranded and single-stranded RNA molecules with 5′ Triphosphates and their use for inducing interferon
#36G-quadruplex binding assays and compounds therefor
#37Suppressors of CpG oligonucleotides and methods of use
#38Piggy-back delivery of nucleic acids into organisms
#39Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules
#40Method of treating inflammatory arthropathies with supressors of CPG oligonucleotides
#41Suppressors of CpG oligonucleotides and methods of use
#42TOPICAL THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES COMPRISING COMPOUND CAPABLE OF BINDING SPECIFICALLY TO DNA SEQUENCE
#43G-QUADRUPLEX BINDING ASSAYS AND COMPOUNDS THEREFOR
#44PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS
#45Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides
#46Multiple CpG oligodeoxynucleotide and their use to induce an immune response
#47Use of inhibitory oligonucleotides to treat autoimmune disease
#48Combination Therapies Against Cancer
#49Nucleic acid comprising zwitterionic nucleotides
#50Antiviral Oligonucleotides Having a Conserved G4 Core Sequence
#51USE OF G-RICH OLIGONUCLEOTIDES FOR TREATING NEOPLASTIC DISEASES
#52Ultra-small RNAs as toll-like receptor-3 antagonists
#53MODULATION OF OLIGONUCLEOTIDE CPG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
#54Inhibitors of DNA Immunostimulatory Sequence Activity
#55Packaging of Immunostimulatory Substances Into Virus-Like Particles: Method of Preparation and Use
#56Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
#57GUANOSINE-RICH OLIGONUCLEOTIDES AS AGENTS FOR INDUCING CELL DEATH IN EUKARYOTIC CELLS
#58Levels and/or sustainability of DNA-based gene expression
#59METHODS AND PRODUCTS TO TARGET, CAPTURE AND CHARACTERIZE STEM CELLS
#60Suppressors of CpG oligonucleotides and methods of use
#61IMMUNOSTIMULATORY OLIGONUCLEOTIDES WITH MODIFIED BASES AND METHODS OF USE THEREOF
#62Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides
#63Methods, compositions, and kits for modulating tumor cell proliferation
#64Methods and compositions for the treatment of uveitis
#65G-quartet oligonucleotides that target hypoxia-inducible factor 1-α (HIF1α)
#66Methods of nonspecific target capture of nucleic acids
#67Immunomodulatory polynucleotides and methods of using the same
#68Double-stranded and single-stranded RNA molecules with 5′ triphosphates and their use for inducing interferon
#69Guanosine rich oligonucleotides and methods of inducing apoptosis in tumor cells
#70Multiple CpG oligodeoxynucleotides and their use to induce an immune response
#71G-rich polynucleotides as a novel therapeutic for the treatment of huntington's disease
#72Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
#73Modulation of telomere length by oligonucleotides having a G-core sequence
#74ANTIGENIC COMPOSITION
#75Therapeutically useful synthetic oligonucleotides
#76G-rich polynucleotides for the treatment of Huntington's Disease
#77Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
#78Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies
#79Antiviral oligonucleotides having a conserved G4 core sequence
#80Oligonucleotide compositions and their use to induce differentiation of cells
#81Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
#82Double-stranded and single-stranded RNA molecules with 5 ' triphosphates and their use for inducing interferon
#83Enzymatic nucleic acid treatment of diseases or conditions related to levels of IKK-gamma and PKR
#84Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
#85Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
#86Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
#87Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides
#88RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNA
#89Method for inhibiting NF-kappa B signaling and use to treat or prevent human diseases
#90RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)
#91Novel inhibitors of poxvirus replication
#92Immune stimulation by phosphorothioate oligonucleotide analogs
#93Method for stabilising of nucleic acids
#94RNA-based transcriptional regulators
#95Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
#96Oligonucleotides, agents containing these oligonucleotides, and the use thereof
#97Long noncoding RNAs and cell reprogramming and differentiation
#98Long noncoding RNAs and cell reprogramming and differentiation
#99Long noncoding RNAS and cell reprogramming and differentiation